Zusammenfassung
Weltweit werden jährlich etwa 1,5 Millionen Hüftgelenksendoprothesen, davon etwa 120000 in Deutschland, implantiert. Hierzu addiert sich eine nicht unerhebliche Anzahl weiterer Gelenksprothesen, wie Kniegelenk-, Sprunggelenk-und Schultergelenkendoprothesen. Die Implantation von Endopro-thesen ist für einen Großteil der Patienten eine erfolgreiche Operation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Astrand J, Aspenberg P (1999) Alendronate did not inhibit instability-induced bone resorption. A study in rats. Acta Orthop Scand 70:67–70
Astrand J, Skripitz R, Aspenberg P (2000) Alendronate Reduces Osteolysis Induced By Fluid Pressure in a Rat Model. Proc Orthopaedic Research Society Orlando 524
Bragdon CR, Biggs S, Wintle S, Jasty M, Rubash HE, Harris WH (2000) Inhibition of disuse osteopenia around a canine ther under the influence of alendronate. Proc Orthopaedic Research Society Orlando, p 137
Fleisch H (1998) Bisphosphonates: mechanisms of action. Endocr Rev 19:80–100
Goodship AE, Lawes TJ, Green J, Eldridge JD, Kenwright J (1998) The Use of Bisphosphonates to Inhibit Mechanically Related Bone Loss in Aseptic Loosening of Hip Protheses. Trans Orthop Res Soc 2
Horowitz SM, Algan SA, Purdon MA (1996) Pharmacologic inhibition of particulate-induced bone resorption. J Biomed Mater Res 31:91–96
Jingushi S, Yasuda K, Sakai H, Azuma Y, Ohta T, Iwamoto Y (2000) Alendronate prevents bone resorption by isolated cells from periprosthetic granulation tissue in hips of revision total hip arthroplasty. Trans Orthop Res Soc, p 1
Kurth AA (2000) Osseointegration of metal Implants after Ibandronate treatment, (unpublished data)
Li J, Mori S, Kaji Y, Mashiba T, Kawanishi J, Norimatsu H (1999) Effect of bispho-sphonate (Incadronate) on fracture healing of long bones in rats. J Bone Miner Res 14:969–979
Lind M, Overgaard S, Ongpipattanakul B, Ngyen T, Bünger C, Soballe K (1996) Transforming Growth Factor Betal stimulates bone ongrowth to weight-loaded tricalcium phosphate coated implants. J Bone Joint Surg [Br] 78B:377–382
Madsen JE, Berg-Larsen T, Kirkeby OJ, Falch JA, Nordsletten L (2000) No adverse effect of clodronate on fracture healing in rats. Acta Orthop Scand 69:532–536
Meraw SJ, Reeve CM, Wollan PC (1999) Use of alendronate in peri-implant defect regeneration. J Periodontol 70:151–158
Milett PJ, Allen AJ, Doty S, Felker K, Izanec JL, Toledano S, Bostrom M (2000) Effects of alendronate on particulate-induced osteolysis in a rat model. Trans Orthop Res Soc, p 869
Pataki A, Müller K, Green JR, Ma YF, Li QN, Jee WS (1997) Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: a comparative histomorphometric study on the cancellous bone formed before, during, and after treatment. Anat Rec 249:458–468
Pilliar SM, Lee JM, Maiatopolous C (1986) Observations of the effect of movement on bone ingrowth into porous-surfaced implants. Clin Orthop 208:108–113
Rader CP, Baumann B, Rolf O, Eulert J (1999) TNF-alpha-Ausschüttung durch Abriebpartikel im humanen Makrophagenmodell und deren Beeinflussung durch Medikamente. Z Orthop 137:A70
Riley EH, Lane J, Urist M, Lyons KM, Lind M (1996) Bone Morpho-Genetic Protein-2:Biology and Application. Clin Orthop 324:39–46
Sabokbar A, Fujikawa Y, Murray DW, Athanasou NA (1998) Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption. Ann Rheum Dis 57:614–618
Shanbhag AS, Hasselman CT, Rubash HE (1997) Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model. Clin Orthop 33–43
Shanbhag AS, Kenney JA, Manning C, Flannery M, Rubash HE, Goldring SR (2000) Mitogenic effect of bisphosphonates on osteoblastic cells. Proc Orthopaedic Research Society Orlando, pp 688
Shanbhag AS, May D, Cha C, Kovach C, Rubash HE (1999) Enhancing net bone formation in canine total hip components with bisphosphonates. Trans Orthop Res Soc 255
Skripitz R, Aspenberg P (2000) Implant fixation enhanced by intermittent parathyroid hormone treatment. Proc Orthopaedic Research Society Orlando, pp 326
Spector M, Shortkoff S, Hsu HP, Lane N, Sledge CB, Thornhill TS (1990) Tissue Changes Around Loose Protheses: A canine model to investigate the effects of an antiinflammatory agent. Clin Orthop 261:140–152
Stanton L (1998) American Academy of Orthopaedic Surgeons arthroplasty and total joint replacement procedures: United States 1990-1995. http://www.aaos.org/word-htlm/press/arthropl.htm
Thadani PJ, Waxman B, Sladek E, Gonzalez MH, Barmada R (1999) Inhibition of particulate debris induced osteolysis by alendronate in a rat model. Trans Orthop Res Soc, pp 321
Wooley PH, Sud S, Robbins PD, Whalen JD, Evans CH (1999) Contrasting effects of gen therapy to inhibit interleukin-1 beta or tumor necrosis factor alpha in the murine inflammatory response to wear particles. Trans Orthop Res Soc 23:122
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kurth, A.A. (2001). Experimentelle Untersuchungen zur Anwendung einer antiosteolytischen Therapie in der Endoprothetik. In: Kurth, A.A., Hovy, L., Hennigs, T. (eds) Bisphosphonattherapie von Knochenerkrankungen. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57626-3_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-57626-3_12
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-7985-1266-5
Online ISBN: 978-3-642-57626-3
eBook Packages: Springer Book Archive